TheFly.com
ENVB
Enveric Biosciences
$
()
Enveric in out-licensing deal for chemical entities to treat joint diseases
USPTO issues patent to Enveric titled 'Multi-Substituent Psilocybin Derivatives'
Enveric Biosciences to sell 228,690 shares at $1.41 in direct offering
Enveric in compound out-licensing deal with biotech firm with
Enveric Biosciences to sell cancer-related patent portfolio, terms undisclosed
Enveric Biosciences initiated with bullish view at H.C. Wainwright, here's why
Enveric Biosciences files to sell 2.24M shares of common stock for holders
Enveric Biosciences sells 1.122M shares at $1.37 in private placement
Enveric Biosciences selects EB-003 as lead in 'next gen' EVM301 series
Enveric Biosciences reports progress on developing lead prodrug candidate EB-373
Copyright ©1998-2024 Thefly.com LLC
